
Cannabidiol (CBD) Market
Cannabidiol (CBD) Market - Global Industry Assessment & Forecast
Segments Covered
By Source Hemp, Marijuana
By Distribution Channel Online, Offline
By End-Use Medical, Personal Use, Pharmaceuticals, Wellness
By Region North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Snapshot
![]() |
2022 - 2028 |
![]() |
2016 - 2021 |
![]() |
USD 4.9 Billion |
![]() |
USD 47.22 Billion |
![]() |
21.3% |
![]() |
Asia Pacific |
![]() |
North America |
Customization Offered
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Market Synopsis:
Global Cannabidiol (CBD) Market is valued at USD 4.9 Billion in 2021 and is projected to attain a value of USD 47.22 Billion by 2028 at a CAGR of 21.3% during the forecast period, 2022–2028. The demand for Cannabidiol (CBD) for health and wellness purposes is strong due to its therapeutic characteristics, which is a major factor driving market growth. Furthermore, increased product acceptance and use as a result of regulatory approvals is likely to promote Cannabidiol (CBD) -infused product production. Cannabidiol (CBD) is the most extensively used Cannabidiol (CBD) for therapeutic purposes due to its absence of psychoactive effects. Cannabidiol (CBD) oil is utilised in a variety of medical applications, including anxiety and depression treatment, stress reduction, diabetes prevention, pain relief, cancer symptom relief, and inflammation relief. The global Cannabidiol (CBD) market is expected to develop at a lucrative rate over the forecast period, owing to the increased acceptance of Cannabidiol (CBD) -based products to treat diseases.
Cannabidiol (CBD) Market Size, 2021 To 2028 (USD Billion)
COVID-19's increased prevalence is expected to have an impact on market growth over the projection period. The COVID-19 dilemma has had a significant and immediate impact on the healthcare industry. Because of the unexpected impact on the supply chain and the limits imposed on manufacturing and supply operations during the early stages of the coronavirus pandemic, most companies suffered a minor loss in the first few quarters. COVID-19, on the other hand, has raised demand for therapeutics, especially Cannabidiol (CBD) , and some important players have seen favourable sales growth as a result of the increased demand.
Large Scale Adoption of Cannabidiol Products as Alternative to Conventional Medicine
Due to the rising prevalence of cancer, an increasing number of individuals are undergoing chemotherapy and experiencing nausea. Muscle disorders have also increased in recent years as a result of countless people around the world adopting a sedentary lifestyle. Cannabidiol (CBD) medications have been shown to be useful against symptoms, and they are becoming increasingly popular among patients. Furthermore, Cannabidiol (CBD) products are subjected to several scientific trials involving the treatment of a variety of illnesses, including neuropathic pain, among others. As a result, while conventional medicine exists to treat such disorders, worries about its adverse effects have paved the door for Cannabidiol (CBD) products to enter the market. Furthermore, regulatory agencies such as the FDA have given it commercial approval due to its shown therapeutic effects.
Limited Approval from the Authorities
Despite the fact that the legal structure is known to promote market demand, various loopholes limit the Cannabidiol (CBD) market's potential growth across sectors. For example, while Cannabidiol (CBD) products are approved for medical and cosmetic use across the globe, regulatory authorities have resisted Cannabidiol (CBD) acceptance as a food and beverage additive. While some states, like as Texas, allow the consumption of hemp-derived Cannabidiol (CBD) -infused foods and beverages, federal authorization is limited, causing bottlenecks in the supply chain.
Market Segmentation:
The Global Cannabidiol (CBD) Market can be segmented by Source Type, into Hemp and Marijuana. Based on Distribution Channel, Online and Offline. Based on End-Use, Medical, Personal Use, Pharmaceuticals and Wellness. Based on Region, the Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Below tree is interactive. You can click the nodes to get more information.
North America to Continue Dominating the Cannabidiol (CBD) Market
North America dominated the market in 2020 and will continue to do so in the future. Some of the primary causes fuelling the region's growth include the existence of a significant population of health-conscious individuals, increased adoption of -based products, the presence of big manufacturers, and the passage of the United States Farm Bill in 2020. North America is widely regarded as the most progressive region in terms of and its derivatives, such as . It boasts the most CBD firms and the most permissive rules regulating the use of CBD products.
Key Players:
Some of the players are Aurora Cannabis, Canopy Growth Corporation, Cronos Group, CV Sciences, Inc., Medterra, and Tilray.
Cannabidiol (CBD) Market is segmented as follows:
Parameter
Details
Segments Covered
Regions & Countries Covered
Companies Covered
Report Coverage
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
impact analysis
Cannabidiol (CBD) Market is tabulated as follows:
FAQ
Frequently Asked Question
What is the global demand for Cannabidiol (CBD) in terms of revenue?
-
The global Cannabidiol (CBD) valued at USD 4.9 Billion in 2020 and is expected to reach USD 47.22 Billion in 2028 growing at a CAGR of 21.3%.
Which are the prominent players in the market?
-
The prominent players in the market are Aurora Cannabis, Canopy Growth Corporation, Cronos Group, CV Sciences, Inc., Medterra, and Tilray.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 21.3% between 2021 and 2028.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Cannabidiol (CBD) include
- Large Scale Adoption of Cannabidiol Products as Alternative to Conventional Medicine
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Cannabidiol (CBD) in 2020.